Pseudomembranous colitis.
D000837:Anion Exchange Resins / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D002981:Clindamycin / Q000009:adverse effects; D003015:Clostridium Infections / Q000150:complications; D003603:Cytotoxins / Q000302:isolation & purification; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy / Q000209:etiology; D005243:Feces / Q000032:analysis; D006801:Humans; D007413:Intestinal Mucosa / Q000473:pathology; D007962:Leukocytes; D008034:Lincomycin / Q000009:adverse effects; D008795:Metronidazole / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use
D000837:Anion Exchange Resins; D000900:Anti-Bacterial Agents; D003603:Cytotoxins; D008795:Metronidazole; D002981:Clindamycin; D014640:Vancomycin; D008034:Lincomycin